Vogliboz GM 2mg/500mg/0.2mg Tablet
Vogliboz GM 2mg/500mg/0.2mg Tablet
Introduction to Vogliboz GM 2mg/500mg/0.2mg Tablet
Vogliboz GM 2mg/500mg/0.2mg Tablet is a prescription-only medicine and is a potent triple drug combination formulated with Voglibose, Glimepiride, and Metformin hydrochloride to deliver effective control over Type II diabetes. This specialized medication is recommended for challenging cases, ensuring comprehensive management of diabetes.
Voglibose contributes by retarding the digestion and absorption of carbohydrates, Glimepiride stimulates insulin secretion, and Metformin Hydrochloride (SR) enhances insulin sensitivity. Together, they form a powerful trio targeting different aspects of glucose control, providing a multifaceted strategy against Type II diabetes.
Typically, it is taken orally, and the dosage may vary based on individual health parameters. It is often recommended to take the medication with a meal to optimize its effectiveness.
Users should be aware of potential side effects. These may include gastrointestinal discomforts such as diarrhea, abdominal pain, and nausea. Fluctuations in blood sugar levels and other reactions are possible Promptly report any adverse effects to your healthcare professional.
Individuals with specific health conditions, such as kidney or liver disorders, should exercise caution. Pregnant or breastfeeding individuals, as well as those with known allergies to any of the components, should consult their healthcare provider before starting this medication.
In the event of a missed dose, take it as soon as remembered unless it's close to the next scheduled dose. Do not double up to compensate for a missed dose.
Related Faqs
Are there any specific conditions in which Glimda-MV 2 Tablet SR should not be taken?
Patients who have a known allergy to any of the ingredients or excipients present in GlimdaMV 2 Tablet SR should refrain from using this medication It is similarly contraindicated for individuals with moderate to severe kidney disease Additionally patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis are also advised against taking this medicine Patients who have experienced an allergic reaction to GlimdaMV 2 Tablet SR or any of its components should avoid using this medication Furthermore individuals with significant kidney impairment should not take this medicine It is also not recommended for patients with inflammatory bowel disease colonic ulcerations or underlying metabolic acidosis such as diabetic ketoacidosis Those who have a known hypersensitivity to the ingredients or excipients in GlimdaMV 2 Tablet SR should refrain from using this medication Likewise individuals with moderate to severe kidney disease and patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine Patients who have a known allergy to any of the components or excipients of GlimdaMV 2 Tablet SR should refrain from using this medication Similarly individuals with moderate to severe kidney disease and patients who have inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine It is imperative that patients who have a known allergic reaction to any of the ingredients or excipients of GlimdaMV 2 Tablet SR should avoid using this medication Additionally this medicine is not recommended for patients with moderate to severe kidney disease or those with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis
What are the instructions for the storage and disposal of Glimda-MV 2 Tablet SR?
To ensure the effectiveness and safety of this medication it is crucial to store it appropriately Always keep the medicine in its original packet or container making sure to tightly close it after each use Follow the storage instructions provided on the packaging or label to maintain its stability and potency Proper storage conditions can vary depending on the medication so it is important to refer to the specific guidelines outlined When it comes to disposing of any unused medication take extra care to prevent accidental consumption by pets children or other individuals Safely discard the medicine in a responsible manner as per the recommended disposal procedures By practicing proper storage and disposal methods you can play an active role in promoting medication safety for both yourself and those around you
What is Glimda-MV 2 Tablet SR?
Glimda-MV 2 Tablet SR is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.
What is Glimitip-MV?
GlimitipMV is a powerful combination of Glimepiride Metformin and Voglibose three potent medicines used for the treatment of type 2 diabetes mellitus DM Designed to improve blood glucose levels in adults this medication is an integral part of a comprehensive treatment plan that includes a balanced diet and regular exercise Glimepiride one of the active ingredients in GlimitipMV effectively lowers blood glucose levels by stimulating the pancreas to release more insulin This hormone plays a crucial role in regulating blood sugar levels Metformin another key component acts by reducing glucose production in the liver and improving insulin sensitivity further contributing to better glycemic control Voglibose the third ingredient in GlimitipMV is an alphaglucosidase inhibitor that efficiently lowers postprandial glucose levels By inhibiting the enzymes responsible for breaking down carbohydrates in the intestine Voglibose delays glucose absorption and helps maintain more stable blood sugar levels after meals It is important to note that GlimitipMV is specifically intended for the treatment of type 2 diabetes mellitus and should not be used for type 1 diabetes As a comprehensive combination medication GlimitipMV offers a multifaceted approach to managing diabetes and promoting better blood glucose control in affected individuals
What are the possible side effects of Vogliboz-GM?
VoglibozGM while beneficial in managing certain health conditions may come with some commonly observed side effects One of the potential effects is hypoglycemia which refers to a low blood sugar level and can cause discomfort Nausea and diarrhea are also reported as possible side effects which may lead to feelings of unease and frequent bowel movements Some individuals may experience an altered taste sensation resulting in a temporary change in how food and beverages are perceived Flatulence stomach pain and headaches are additional side effects that have been associated with VoglibozGM Skin rashes have been reported in certain cases which can cause itchiness or discomfort Lastly there is a possibility of respiratory tract infections occurring as a side effect of using VoglibozGM Its important to note that these side effects may not affect everyone and individuals should consult their healthcare provider if they experience any concerning symptoms while taking this medication
Are there any specific conditions in which Vogliboz-GM should not be taken?
It is of utmost importance to avoid the usage of VoglibozGM in patients who have a verified allergic reaction to any of the components or additives found in this medication Additionally individuals with moderate to severe kidney disease should refrain from using this medicine Similarly those with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis are strongly advised against the use of this medication It is essential to prioritize patient safety by adhering to these precautionary measures Allergic reactions can range from mild discomfort to severe complications and it is crucial to prevent any potential harm Patients with kidney disease may experience further deterioration in their condition if they use VoglibozGM as the medication may not be effectively eliminated from the body For individuals with inflammatory bowel disease colonic ulcerations or underlying metabolic acidosis the use of this medicine could exacerbate their existing conditions and lead to further complications Therefore it is strongly recommended that they avoid the use of VoglibozGM to prevent any adverse effects In conclusion it is vital to exercise caution when prescribing and using VoglibozGM ensuring that patients with known allergies or specific medical conditions are aware of the risks associated with its usage By prioritizing patient safety healthcare providers can make informed decisions and help prevent any potential harm
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
Vogliboz GM 2mg/500mg/0.2mg Tablet
Prescription Required
Packaging :
strip of 10 tablets
Manufacturer :
Knoll Pharmaceuticals LtdMRP :
Related Posts
1:15
5 Healthier Sugar Alternatives!
1:15
Pregnancy and Diabetes: What to Eat? | Foods to Eat for Gestational Diabetes!
1:15
3 Practical Tips to Improve Quality of Life for Dementia Patients!
1:15
Vidya Balan's Weight Loss: Proven Tips for Your Dream Body!
1:15
3 lifestyle changes that can help reduce the risk of Dementia!
1:15
The Impact of long term untreated Sleep Apnea on Your Health!
1:15
The dangers of too much caffeine consumption!
.svg)
